Zeskind Benjamin J.
SEC CIK 1870062 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| IMRX | Immuneering Corp | Pres, CEO, Dir, 10% | 2.32M | $254.6K | — | 11 | 2021-08-03 | 2026-06-23 |
Most active insiders at IMRX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Feinberg Peter | Dir | $225.7K | — |
| 2 | Schall Thomas J. | Dir | $101.1K | — |
| 3 | Hall Brett Matthew | CSO | $35.5K | — |
| 4 | Brakewood Harold Eugene | Chief Business Off | $25.0K | — |
| 5 | Neufeld Leah R | CHRO | $16.0K | — |
| 6 | Zeskind Benjamin J. | Pres AND CEO, Dir | $10.9K | — |
| 7 | Bookman Michael | CLO, Sec | $6,967 | — |
| 8 | Morales Mallory | CAO | $1,917 | — |
Transactions 11
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-24 16:11 | 2026-06-23 | IMRX | Immuneering Corp | Zeskind Benjamin J. | Pres AND CEO, Dir | P - Purchase | $4.56 | +2,400 | 2.32M | +0.1% | +$10.9K | |
| M | 2025-07-03 | 2025-07-01+ | IMRX | Immuneering Corp | Zeskind Benjamin J. | Pres AND CEO, Dir, 10% | P - Purchase | $3.49 | +10.0K | 2.31M | +0.4% | +$34.9K |
| 2025-06-20 | 2025-06-18 | IMRX | Immuneering Corp | Zeskind Benjamin J. | Pres AND CEO, Dir, 10% | P - Purchase | $2.39 | +21.0K | 2.30M | +0.9% | +$50.2K | |
| 2024-03-19 | 2024-03-19 | IMRX | Immuneering Corp | Zeskind Benjamin J. | Pres AND CEO, Dir, 10% | P - Purchase | $2.77 | +20.0K | 2.28M | +0.9% | +$55.4K | |
| D | 2022-12-27 | 2022-12-22 | IMRX | Immuneering Corp | Zeskind Benjamin J. | Pres AND CEO, Dir, 10% | M - OptEx | $3.01 | +2,500 | 2.26M | +0.1% | +$7,525 |
| D | 2022-04-14 | 2022-04-12 | IMRX | Immuneering Corp | Zeskind Benjamin J. | Pres AND CEO, Dir, 10% | M - OptEx | $3.01 | +2,000 | 2.26M | +0.1% | +$6,020 |
| 2022-03-24 | 2022-03-23 | IMRX | Immuneering Corp | Zeskind Benjamin J. | Pres AND CEO, Dir, 10% | P - Purchase | $8.02 | +3,000 | 2.26M | +0.1% | +$24.1K | |
| D | 2022-03-01 | 2022-02-28 | IMRX | Immuneering Corp | Zeskind Benjamin J. | Pres AND CEO, Dir, 10% | M - OptEx | $3.01 | +2,000 | 2.25M | +0.1% | +$6,020 |
| 2021-09-14 | 2021-09-13 | IMRX | Immuneering Corp | Zeskind Benjamin J. | Pres AND CEO, Dir, 10% | P - Purchase | $22.87 | +2,083 | 2.60M | +0.1% | +$47.6K | |
| D | 2021-08-04 | 2021-08-03 | IMRX | Immuneering Corp | Zeskind Benjamin J. | Pres, CEO, Dir, 10% | C - Cnv Deriv | — | +49.1K | 2.60M | +2% | — |
| D | 2021-08-04 | 2021-08-03 | IMRX | Immuneering Corp | Zeskind Benjamin J. | Pres, CEO, Dir, 10% | P - Purchase | $15.00 | +2,098 | 2.60M | +0.1% | +$31.5K |
Purchase Sale Sale after option exercise All abbreviations